City

Cincinnati (1)

Houston (1)

Overall Status

Recruiting (1)

Terminated (1)

Sign in for free

Phase

early phase 1 (1)

phase 2 (1)

Sponsor

Children's Hospital Medical Center, Cincinnati (1)

M.D. Anderson Cancer Center (1)

Collaborator

National Cancer Institute (NCI) (1)

Study Documents

Intervention Type

drug (2)

biological (1)

Funder Type

Other (2)

Study Type

Interventional (2)

refractory lymphoblastic lymphoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recurrent Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Burkitt Leukemia Trial in Houston

Recruiting

Recurrent Acute Lymphoblastic Leukemia
+10 more

Bortezomib
+8 more

Houston, Texas

M D Anderson Cancer Center

Sep 21, 2022

Relapsed Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Refractory Acute Lymphoblastic Leukemia Trial in

Terminated

Relapsed Lymphoblastic Leukemia
+3 more

Sirolimus

Cincinnati, Ohio

Cincinnati Children's Hospital Medical Center

Sep 10, 2020